menu

Reviewing RSV in Immunocompromised Adults

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Reviewing RSV in Immunocompromised Adults

ReachMD Healthcare Image
Restart
Resume
Choose a format
Take Post SurveySkip straight to the post survey if you have already participated in this activity
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Related
Comments
  • In Partnership with

  • Overview

    It’s estimated that respiratory syncytial virus (RSV) is responsible for up to 30 percent of viral respiratory infections in the stem cell transplant population. So how can we help RSV patients achieve their best outcomes? Learn more with Dr. Ryan Maves as he speaks with Dr. Kelly Pennington, Assistant Professor of Medicine at the Mayo Clinic in Rochester, Minnesota.

    This program is produced in partnership with the American College of CHEST Physicians and is supported by an educational grant from GSK.

Facebook Comments

Recommended
Details
Presenters
Related
Comments
  • In Partnership with

  • Overview

    It’s estimated that respiratory syncytial virus (RSV) is responsible for up to 30 percent of viral respiratory infections in the stem cell transplant population. So how can we help RSV patients achieve their best outcomes? Learn more with Dr. Ryan Maves as he speaks with Dr. Kelly Pennington, Assistant Professor of Medicine at the Mayo Clinic in Rochester, Minnesota.

    This program is produced in partnership with the American College of CHEST Physicians and is supported by an educational grant from GSK.

Facebook Comments

Schedule18 Apr 2024